CD45R 분자 정보
Molecule Name
Leukocyte common antigen
분자 별명
CD45R
Drug Development Progress
임상 약물 수3
시판 약물 수0
최고 연구 개발 단계Phase 3 Clinical
표적 별명
PTPRC，T200，CD45，Protein Tyrosine Phosphatase， Receptor Type C，CD45 Antigen，L-CA，Protein Tyrosine Phosphatase， Receptor Type， C Polypeptide，Receptor-Type Tyrosine-Protein Phosphatase C，T200 Leukocyte Common Antigen，Leukocyte Common Antigen，T200 Glycoprotein，EC 3.1.3.48，CD45R，GP180，B220，LCA，LY5，Leukocyte Common Antigens，Protein Tyrosine Phosphatase Receptor Type C，EC:3.1.3.48
제품 문의
임상 약물 정보
| 영어 이름 | 연구 코드 | 연구 개발 단계 | 회사 | 적응증 | 임상 시험 |
|---|---|---|---|---|---|
| Immunomodulatory progenitor cell therapy (Celixir) | Phase 3 Clinical | Celixir | Endomyocardial Fibrosis; Cardiomyopathies | 상세 | |
| I-131-Apamistamab | BC8-I-131; BC-8; 131IBC8 | Phase 3 Clinical | Fred Hutchinson Cancer Research Center | Neoplasms, Gonadal Tissue; Lymphoma, Mantle-Cell; Sezary Syndrome; Lymphoma, Non-Hodgkin; Leukemia, Myeloid, Acute; Lymphoma; Burkitt Lymphoma; Intraocular Lymphoma; Lymphoma, T-Cell; Lymphoma, Follicular; Waldenstrom Macroglobulinemia; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell, Cutaneous; Anemia, Sideroblastic; Angioimmunoblastic T-cell Lymphoma; Leukemia, Large Granular Lymphocytic; Leukemia, Lymphocytic, Chronic, B-Cell; Mycosis Fungoides; Leukemia-Lymphoma, Adult T-Cell; Leukemia; Lymphoma, B-Cell, Marginal Zone; Lymphoma, T-Cell, Peripheral; Hematopoietic stem cell transplantation (HSCT); Neoplastic Cells, Circulating; Leukemia, Hairy Cell; Anemia, Refractory, with Excess of Blasts; Lymphoma, Large B-Cell, Diffuse; Lymphoma, B-Cell; Myelodysplastic Syndromes; Leukemia, Myelomonocytic, Chronic; Hodgkin Disease; Lymphoma, Large-Cell, Immunoblastic; Lymphomatoid Granulomatosis; Lymphoma, Extranodal NK-T-Cell; Pancytopenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 상세 |
| At 211 MAb BC8-B10 | Phase 2 Clinical | Fred Hutchinson Cancer Research Center | Neoplasms | 상세 |